What is the valley of death of science and biotech? For those of us conducting stem cell research, especially human stem cell research, I don’t have to tell you how expensive it is. Even just doing pre-clinical or basic science research costs a fortune. When you start talking about the kind of pre-clinical research specifically […]
The valley of death: stem cells, biotechs, and money Read More »
What are the stem cell talking points for politicians and how should scientists talk to them? In the debate over funding for embryonic stem cell research, it is usually assumed that Democrats are in favor of embryonic stem cell research and that Republicans are opposed. But recent polls suggest that amongst the U.S. population as
Greatest hits: stem cell talking points for Republicans Read More »
What stem cell treatments have you had? UPDATE: I’ve now updated the poll to allow readers to choose up to 2 answers since this is important given the new option of “If facing a disease…” One of the cool things about writing this blog is that I get to meet so many amazing people including
Stem Cell Treatments Poll Read More »
What are the top stem cell blogs and websites? Who decides? Americans and people all over the world are inexorably changing how they get their information. While newspapers and the nightly news used to spoon-feed us the “top stories” in the news, their heyday is over and now most people get their news and information
What are the top stem cell blogs and websites in the world Read More »
While most readers here tell me they greatly value our stem cell blog, after some threats I’m wondering: is it time to shut this blog down? Some people are saying I should or else! Unfortunately, threats to scientists, scientific openness, and science itself are not unusual. This stem cell blog in its current incarnation has
Shut Down This Stem Cell Blog or Else! Read More »
Viacyte is one of the most exciting biotechs in the stem cells for diabetes space. Dr. Kevin D’Amour, Director of Stem Cell Research at Viacyte, gave an excellent, extremely interesting talk Friday morning: Developing an Encapsulated Stem Cell Therapy for Diabetes. Viacyte talk In the talk, Dr. D’Amour gave a very detailed description of their
We’ve all been closely following Geron and its work on ES cells. This morning there was a fantastic session here at the ASGCT meeting in Seattle on Clinical Trials on Stem Cells. Talk by Geron One of the speakers was Geron VP, Jane Lebkoswki, PhD: Development of Human Embryonic Stem Cell-Based Therapies for Treatment of
Stem Cell Clinical Trials Part I: Geron VP Lebkoswki speaking today in Seattle Read More »
Email me your job opening if you are an employer and I’ll post it for free. If you are a job seeker, email me your info and I’ll post that for free. Job Openings 2013 for stem cells. Are you a grad student wrapping up your PhD in the next year or so? Have
The best talk today was the keynote address by Dr. George Daley focused mostly on iPS cells. Dr. Daley is one of the world’s experts on iPS cells and pluripotent stem cells more generally. He covered many interesting elements of the iPS cell field including the genetic mutations that seem to occur during the reprogramming
Summary of George Daley talk on iPS cells today in Seattle Read More »
There were three talks today on iPS cells here at the American Society for Gene and Cell Therapy meeting or ASGCT meeting in Seattle. Dr. James Ellis made the interesting case that it may be preferable to make iPS cells using genetic methods (while everyone else seems to be saying that non-genetic methods will be better).
News on iPS cells from some top scientists at ASGCT meeting today Read More »